Ultragenyx Pharmaceutical, Inc. (RARE)
34.48
-1.76
(-4.84%)
USD |
NASDAQ |
Dec 16, 14:57
Ultragenyx Pharmaceutical Research and Development Expense (Annual): 667.82M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Amicus Therapeutics, Inc. | 109.36M |
| Geron Corp. | 103.74M |
| Vertex Pharmaceuticals, Inc. | 3.630B |
| Fortress Biotech, Inc. | 56.88M |